{"article_title": "Kevin Tracey: Let Patients Decide How Much Risk They'll Take", "article_keywords": ["replied", "right", "theyll", "risk", "vinod", "tracey", "private", "sergey", "patients", "let", "brin", "decide", "regulatory", "portfolio", "venture", "think", "kevin"], "article_url": "http://www.wsj.com/articles/kevin-tracey-let-patients-decide-how-much-risk-theyll-take-1406499046", "article_text": "Earlier this month, at a private conference for the CEOs of his portfolio companies, venture capitalist Vinod Khosla interviewed Google co-founders Sergey Brin and Larry Page, asking them if the company might jump into health care. \"It's just a painful business to be in,\" Mr. Brin replied, later noting that \"the regulatory burden in the U.S. is so high that I think it would dissuade a lot of entrepreneurs.\"\n\nMr. Brin is right. As a neurosurgeon-scientist and entrepreneur who co-founded a bioelectronic...", "article_metadata": {"article.template": "snippet", "article.created": "2014-07-27T22:10:00.000Z", "article.section": "Opinion", "page.region": "na,us", "page.content.type": "Article", "twitter": {"domain": "wsj.com", "description": "In The Wall Street Journal, Kevin Tracey writes that the health-care regulatory burden stops entrepreneurs from getting into the game.", "title": "Let Patients Decide How Much Risk They'll Take", "image": {"src": "https://si.wsj.net/public/resources/images/BN-DV916_tracey_G_20140727124212.jpg", "alt": "Kevin Tracey: Let Patients Decide How Much Risk They'll Take", "identifier": "https://si.wsj.net/public/resources/images/BN-DV916_tracey_D_20140727124212.jpg"}, "site": "@WSJ", "card": "summary_large_image"}, "al": {"ios": {"url": "wsj://launch?articleid=SB10001424052702304453104580037993443917372&headline=Kevin%20Tracey%3A%20Let%20Patients%20Decide%20How%20Much%20Risk%20They%26apos%3Bll%20Take&weburl=http://www.wsj.com/articles/SB10001424052702304453104580037993443917372"}}, "page.site.product": "WSJ", "keywords": "Food and Drug Administration,regulation,government policy,corporate,industrial news,health care policy,commentaries,opinions,health care,life sciences", "news_keywords": "Food and Drug Administration,regulation,government policy,corporate,industrial news,health care policy,commentaries,opinions,health care,life sciences", "article.headline": "Kevin Tracey: Let Patients Decide How Much Risk They'll Take", "cXenseParse": {"candybar": {"image": "https://si.wsj.net/public/resources/images/BN-DV916_tracey_E_20140727124212.jpg"}, "poptart": {"image": "https://si.wsj.net/public/resources/images/BN-DV916_tracey_D_20140727124212.jpg"}}, "description": "In The Wall Street Journal, Kevin Tracey writes that the health-care regulatory burden stops entrepreneurs from getting into the game.", "apple-itunes-app": "app-id=364387007,app-argument=wsj://launch?articleid=SB10001424052702304453104580037993443917372&headline=Kevin%20Tracey%3A%20Let%20Patients%20Decide%20How%20Much%20Risk%20They%26apos%3Bll%20Take&weburl=http://www.wsj.com/articles/SB10001424052702304453104580037993443917372", "user.type": "nonsubscriber", "article.page": "Opinion", "page.content.format": "responsive", "article.summary": "In The Wall Street Journal, Kevin Tracey writes that the health-care regulatory burden stops entrepreneurs from getting into the game.", "page.site": "wsj", "testkeys": "A", "article.published": "2014-07-27T22:44:00.000Z", "dj.asn": "i-4bd1", "robots": "noarchive,noodp", "fb": {"app_id": 368513495882}, "article": {"publisher": "https://www.facebook.com/wsj", "image_count": 1, "word_count": 666}, "viewport": "width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no", "page.section": "Article", "language": "en-US", "og": {"site_name": "WSJ", "description": "In The Wall Street Journal, Kevin Tracey writes that the health-care regulatory burden stops entrepreneurs from getting into the game.", "title": "Let Patients Decide How Much Risk They'll Take", "url": "http://www.wsj.com/articles/kevin-tracey-let-patients-decide-how-much-risk-theyll-take-1406499046", "image": {"width": 553, "identifier": "https://si.wsj.net/public/resources/images/BN-DV916_tracey_G_20140727124212.jpg", "height": 369}, "locale": "en_US", "type": "article"}, "author": "Kevin J. Tracey", "article.access": "paid", "page.content.source": "WSJ Online Article", "article.origheadline": "Let Patients Decide How Much Risk They\u2019ll Take", "article.type": "Commentary (U.S.)", "article.id": "SB10001424052702304453104580037993443917372", "user.exp": "default", "article.updated": "2014-07-27T22:44:00.000Z"}, "article_summary": "Mr. Brin is right.\n\"It's just a painful business to be in,\" Mr. Brin replied, later noting that \"the regulatory burden in the U.S. is so high that I think it would dissuade a lot of entrepreneurs.\"\nEarlier this month, at a private conference for the CEOs of his portfolio companies, venture capitalist Vinod Khosla interviewed Google co-founders Sergey Brin and Larry Page, asking them if the company might jump into health care.\nAs a neurosurgeon-scientist and entrepreneur who co-founded a bioelectronic..."}